#q# [002]

Related by string. #Q# [002] * * chromosome #q# [001] . chromosome #q# [002] . #Q# #Q# Var . #Q# EPS . #Q# YTD . #Q# #Q# QoQ . Geography #Q# #Q# . * DisplaySearch #Q# . #Q# Earnings Release . #q# deletion . #Q# #Q# #Q# QoQ . millions #Q# #Q# . #Q# #Q# Change [001] . #Q# #Q# Change [002] . Type #Q# #Q# . #q# deletion syndrome . #Q# #Q# #Q# #Q# . #Q# #Q# #Q# . YTD #Q# . #Q# #Q# [002] *

Related by context. All words. (Click for frequent words.) 75 #p# [001] 75 #q# [001] 75 chromosome #q# [001] 72 #q#.# [001] 72 #p#.# [002] 72 chromosome #p# [001] 72 #p#.# [001] 72 chromosome #q# [002] 70 PTPN# 69 rs# [002] 69 chromosome #q 68 rs# [003] 68 rs# [004] 68 chromosome #q#.# [001] 68 susceptibility gene 67 microdeletions 67 #q#.# [002] 67 #p# [003] 67 haplotypes 66 heterozygosity 66 VNTR 66 rs# [001] 66 germline mutations 65 susceptibility locus 65 haplotype 65 MSH2 65 intronic 65 chromosome #p#.# 64 CDKN2A 64 MLH1 64 linkage disequilibrium 64 chromosome #q#.# [002] 64 SNP rs# [001] 64 intergenic 64 GSTP1 64 chromosomal regions 64 polymorphisms 63 SNPs 63 variant allele 63 Chromosome 63 chromosome #p# [002] 63 chromosomal aberrations 63 KIAA# 63 haplogroups 63 splice junctions 63 alleles 63 ABCB1 63 ADH1B * 63 somatic mutations 63 CHEK2 63 CDH1 62 TCF#L# gene 62 K ras mutations 62 allele frequencies 62 cytochrome b 62 GNAQ 62 TCF#L# 62 genetic polymorphisms 62 hypermethylated 62 proband 62 homozygosity 62 EGFR gene 62 functional polymorphism 62 3'UTR 62 C#Y 62 miRNA genes 62 dysbindin 62 KRAS mutations 62 genomic deletions 62 intron 61 5 HTTLPR 61 segmental duplications 61 de novo mutations 61 allelic 61 MLL2 61 TP# mutations 61 DQB1 * 61 single nucleotide polymorphism 61 susceptibility genes 61 genetic loci 61 CpG islands 61 caveolin 61 PALB2 61 SLITRK1 61 missense mutation 61 GSTM1 61 variant alleles 61 orthologous 61 heterozygotes 61 genetic polymorphism 61 Supplementary Table 61 BARD1 61 APOE e4 61 polymorphism 61 susceptibility loci 61 loci 61 TYMS 61 #S rRNA 60 genetic variant 60 MYH9 gene 60 paternally inherited 60 cytokeratin 60 TSC1 60 IL#B 60 quantitative trait loci 60 OCA2 60 heterozygous 60 chromosomal rearrangements 60 CNVs 60 autosomal 60 BRAF V#E 60 mitochondrial gene 60 orthologs 60 missense mutations 60 apolipoprotein E gene 60 QTLs 60 promoter methylation 60 HFE gene 60 gene variants 60 LRRK2 gene 60 mutant allele 60 gene locus 60 indel 60 NF1 gene 60 noncoding 60 homozygotes 60 CYP#D# gene 60 SLC#A# [001] 60 hypermethylation 60 CCR5 delta# 60 CYP#C# * 60 FGFR2 60 TOP2A 60 BRCA1 BRCA2 59 IDH1 59 germline mutation 59 mRNA expression 59 trinucleotide 59 LRRK2 mutation 59 ZNF# 59 gene polymorphisms 59 breast cancer genes BRCA1 59 p# mutations 59 immunoreactive 59 KIF6 gene 59 HOTAIR 59 microdeletion 59 HLA DRB1 * 59 UGT#A# * 59 APOC3 59 nucleotide sequence 59 LPA gene 59 apolipoprotein E 59 SNCA 59 cell adhesion molecule 59 R#W [002] 59 adenocarcinomas 59 colorectal carcinoma 59 APOA5 59 NFKBIA 59 G allele 59 TT genotype 59 heterozygote 59 sequence homology 59 genetic variants associated 59 causative mutations 59 DRD2 59 allelic variants 59 ERBB2 59 FMR1 59 receptor gene 59 kilobase 58 dinucleotide 58 indels 58 gene polymorphism 58 RRM1 58 APOL1 58 UTRs 58 ADPKD 58 5q 58 MTHFR 58 lymph node metastasis 58 phenotypic variation 58 p# mutation 58 DRB1 * 58 COL#A# 58 mutated genes 58 repeat allele 58 Haplotype 58 allele 58 genes encoding 58 EGFR mutations 58 periventricular 58 UGT#B# 58 catechol O methyltransferase 58 CYP#C# [002] 58 IKZF1 58 inherited mutations 58 exons 58 SMAD4 58 MSH6 58 variant rs# 58 SLC#A# [002] 58 LRAT 58 telomeric 58 CYP#A# [002] 58 mRNA transcripts 58 At#g# 58 breast carcinomas 58 VHL gene 58 Arabidopsis genome 58 HER2 expression 58 Chromosomal 58 Supplemental Figure 58 rs# rs# 58 BRCA2 mutation 58 chromosome 58 sporadic ALS 58 IgA deficiency 58 HLA DRB1 57 APOE4 57 karyotype 57 gene APOE 57 monogenic 57 single nucleotide polymorphisms 57 genetic variants 57 BMP2 57 V#F mutation 57 DRD4 57 nucleotide sequences 57 KLF4 57 TGFBR1 * 6A 57 cyclin E 57 NR#A# 57 microcephalin 57 missense 57 dopamine transporter gene 57 SNP rs# [002] 57 immunoreactivity 57 mutated K ras 57 FMR1 gene 57 KRAS oncogene 57 HLA DQ2 57 hepatoma 57 CNTNAP2 57 TP# mutation 57 Supplementary Fig 57 gene amplification 57 pathogenic mutations 57 TMPRSS2 ERG 57 virulence genes 57 causal variants 57 MECP2 gene 57 microRNA expression 57 IL#B gene 57 mutations 57 Wwox 57 microsatellite instability 57 ribosomal protein 57 Clusterin 57 MYBPC3 57 polygenic 57 differentially expressed genes 57 ADRB2 57 mtDNA 57 ORFs 57 Li Fraumeni syndrome 57 gene variant 57 CAG repeats 57 ribosomal DNA 57 JAK2 mutation 57 genes BRCA1 57 CC genotype 57 hepatocellular carcinomas 57 Homozygous 57 PARP inhibition 57 ALK gene 57 CREBBP 57 cytogenetic abnormalities 57 CagA 57 HLA B 57 IDH2 57 MYH9 57 hyperplastic 57 chromosomal rearrangement 57 activating mutation 57 MIF protein 57 Plasmodium vivax 57 SHANK3 57 MLL gene 57 lymph node metastases 57 chromosomal 56 methylenetetrahydrofolate reductase 56 KCNQ1 56 CHI#L# 56 genes CYP#C# 56 haplogroup 56 Haplogroup 56 Upregulation 56 somatic mutation 56 mitochondrial DNA mtDNA 56 Genetic variants 56 serine protease 56 alternatively spliced 56 PIK3CA 56 centromeric 56 myeloproliferative 56 G#S [002] 56 mutation 56 uPAR 56 cagA 56 immunoblotting 56 intergenic regions 56 IL#R 56 lysine residues 56 D#N 56 Polymorphisms 56 mtDNA mutations 56 mosaicism 56 IGF2 56 VKORC1 56 clusterin 56 spontaneous mutations 56 EGFR protein 56 amino terminal 56 Papillary 56 metalloprotease 56 Genetic variation 56 hamartomas 56 Histone 56 MTHFR gene 56 forkhead 56 GPC5 56 coding exons 56 Microarray analysis 56 methylation patterns 56 VEGF receptor 56 hypomethylation 56 KCNH2 56 BRCA1 mutation carriers 56 WNK1 56 microsatellite markers 56 3' UTR 56 HNPCC 56 Leukemias 56 IDH1 mutation 56 homozygous 56 DAT1 56 gene encoding 56 dopamine D4 receptor 56 ApoE4 56 polyglutamine 56 TMPRSS2 ERG fusion 56 PRNP 56 anaplastic lymphoma kinase 56 MC1R 56 E#F# 56 exon 56 perilipin 56 adenoma 56 NPY gene 56 autosomal dominant disorder 56 Lewy bodies 56 activating mutations 56 major histocompatibility complex 56 CYP#D# 56 DRD2 gene 56 globin genes 56 chromosomal translocations 56 CpG island 56 cadherin 56 NKX#.# 56 DNA methyltransferase 56 genomewide 56 p# biomarker 56 proto oncogene 56 CALHM1 56 phylogenetic analyzes 56 splice variant 56 homozygote 56 CA1 56 mucinous 56 aneuploidies 56 BRAF V#E mutation 56 coding sequences 56 SPINK1 56 vimentin 56 #q 56 CpG 56 genes differentially expressed 56 genotype 55 nucleotide substitutions 55 parkin gene 55 molecular subtypes 55 gastric carcinoma 55 synuclein 55 CYP#B# 55 fig. S4 55 Dysregulation 55 apolipoprotein E4 55 FLT3 55 GSTT1 55 DNMT1 55 CNTNAP2 gene 55 Activating mutations 55 BRCA1 mutations 55 paralogs 55 nitrotyrosine 55 LRP6 55 HLA DR 55 distinct subtypes 55 SNPs pronounced snips 55 ABCB1 gene 55 FGFR3 55 tumor suppressor gene 55 Alleles 55 HGPIN 55 miR #a [001] 55 Prox1 55 normal karyotype 55 Immunohistochemical analysis 55 basal forebrain 55 LRP5 55 chromosomal alterations 55 promoter hypermethylation 55 Genotypes 55 monozygotic twins 55 HLA B# 55 apoE4 55 astrocytic 55 constitutively expressed 55 matrix metalloproteinase 55 inferior frontal 55 immunohistochemical 55 membrane proximal 55 APOE e4 gene 55 CDH# 55 phenotype 55 hypoperfusion 55 BRCA2 gene 55 KRAS mutation 55 PON1 55 Overexpression 55 lymphovascular invasion 55 subcellular localization 55 nucleotide 55 N acetyltransferase 55 ChIP Seq 55 K ras gene 55 human leukocyte antigen 55 PTEN gene 55 CIN2 + 55 ESR1 55 MAPK pathway 55 IRF6 55 TTR gene 55 Y chromosomal 55 receptor tyrosine kinase 55 chromosomal deletions 55 PCa 55 LIS1 55 allele frequency 55 codons 55 alpha synuclein gene 55 DNA methylation patterns 55 BRCA2 mutation carriers 55 cis regulatory 55 hypervariable 55 penetrance 55 PNET 55 RUNX3 55 succinate dehydrogenase 55 heterozygosity LOH 55 3q 55 NAT2 55 Immunohistochemical staining 55 AMACR 55 malignant nodules 55 ubiquitinated 55 IDH1 gene 55 HMGA2 55 SCN5A 55 TAp# 55 #q deletion 55 familial aggregation 55 OGG1 55 constitutively active 55 MGUS 55 inactivating mutations 55 progranulin gene 55 nucleoli 55 segmental duplication 55 raphe 55 CISH 55 evolutionarily conserved 55 genomic rearrangement 55 Tumor Suppressor 55 APOE 55 genetic variation 55 gene 55 unmethylated 55 H#K#me# 55 polycystin 55 Alu elements 55 glycogen synthase kinase 55 EAAT2 55 autosomal recessive 55 PICALM 54 mutated BRCA1 54 maternally inherited 54 colorectal carcinomas 54 CD# expression [001] 54 MDR1 54 CHD7 54 chromosomal instability 54 SLC#A# gene [001] 54 myeloproliferative neoplasms 54 CEACAM1 54 GABRA2 54 K#N 54 melatonin receptor 54 BRAF protein 54 MAP#K# 54 PTEN mutations 54 tyrosine kinase receptor 54 striatal 54 subventricular zone 54 P cadherin 54 K#R [002] 54 MMP9 54 meiotic recombination 54 substrate specificity 54 HepG2 cells 54 immunohistochemical analysis 54 transcriptional profiles 54 PKD1 54 number variations CNVs 54 CDK4 54 homodimer 54 palladin 54 C#T [002] 54 SOCS3 54 generalized vitiligo 54 splice variants 54 gastric adenocarcinoma 54 Heterozygous 54 glutathione S transferase 54 gene mutation 54 methylated 54 genetic variations 54 CYP#C# [001] 54 circadian genes 54 entorhinal cortex 54 transmembrane protein 54 BMPR2 54 NKX2 54 NPM1 gene 54 Polymorphism 54 lymphoid cells 54 chimpanzee genomes 54 APOE gene 54 melanocytic nevi 54 IGFBP 54 differential gene expression 54 TIMP 1 54 APOE4 gene 54 Histologic 54 caveolae 54 hormone receptor negative 54 frameshift mutation 54 PDGFR alpha 54 G6PD 54 IRAK1 54 interleukin IL 54 autism susceptibility genes 54 homeobox gene 54 protein encoded 54 progressive neurodegenerative disorder 54 genetic markers 54 WT1 54 ApoE 54 homology 54 serotonin receptor 54 TOP2A gene 54 colorectal neoplasia 54 pRb 54 PALB2 gene 54 sensu lato 54 receptor kinase 54 sCJD 54 EGFP 54 pseudogenes 54 HMGA1 54 proline rich 54 BRAF mutations 54 apolipoprotein E APOE 54 coding genes 54 genomic instability 54 PDGFRA 54 A. thaliana 54 familial pancreatic cancer 54 mitogen activated protein kinase 54 del 5q 54 anterior temporal 54 Li Fraumeni 54 immunohistochemical staining 54 advanced adenoma 54 HER2 neu 54 miR #a [002] 54 thyroid carcinoma 54 FSHR 54 APOE allele 54 familial adenomatous polyposis FAP 54 Phylogenetic analysis 54 seminomas 54 chemokine receptor 54 atypical hyperplasia 54 malignant neoplasm 54 Apc 54 fractional anisotropy 54 familial ALS 54 mesotheliomas 54 neurofibromatosis type 54 phenotypically 54 retinol binding protein 54 kD 54 subgenual cingulate 54 number variation CNV 54 SCN1A 54 alpha synuclein protein 54 cisplatin resistant 54 T#I [002] 54 invasive lobular 54 null mice 54 HER2 receptor 54 breast carcinoma 54 prostate cancer CaP 54 amino acid substitutions 54 genetic mutations 54 epigenetic modification 54 EBNA1 54 polyadenylation 54 clinicopathologic 54 Ser# 54 transthyretin amyloidosis 54 histologic subtype 54 protein isoforms 54 deleterious mutation 54 Brugada syndrome 53 frontotemporal dementia 53 APOE ε4 53 downregulation 53 matrix metalloproteinase MMP 53 genes predisposing 53 colorectal neoplasms 53 clade B 53 serous ovarian cancer 53 D. melanogaster 53 CD#b 53 radial glia 53 prognostic marker 53 probands 53 pulvinar 53 cytoplasmic domain 53 microglial 53 c KIT 53 MeCP2 gene 53 LDL receptor 53 adiponectin concentrations 53 JAK STAT 53 MC1R gene 53 etiologic 53 periaqueductal gray 53 dopamine receptor gene 53 NQO1 53 serine threonine kinase 53 carboxy terminal 53 HOMA IR 53 EphB4 53 TMEM#B 53 metaplasia 53 genotypes 53 genome rearrangements 53 CFH gene 53 autosomal dominant 53 vitamin D receptor 53 LKB1 53 nonsense mutations 53 isotype 53 miR #b [002] 53 phospho 53 PDGFR 53 SORL1 53 carboxyl terminal 53 independent prognostic marker 53 spontaneous mutation 53 DICER1 gene 53 BRCA1 gene 53 DLC1 53 EoE 53 heritable 53 CFTR gene 53 MEF2A 53 supratentorial 53 p# MAPK 53 haematopoietic 53 Phosphorylation 53 TUNEL 53 EGFR mutation 53 Jhdm2a 53 CYP #D# 53 osteoprotegerin 53 extracellular domain 53 seropositivity 53 beta1 integrin 53 HER2 amplification 53 muscarinic receptor 53 gene MECP2 53 G#S mutation 53 ERK signaling 53 KRAS wild 53 Hashimoto thyroiditis 53 monocyte 53 nephronophthisis 53 Multivariate analysis 53 Western blotting 53 aneuploidy 53 amino acid substitution 53 IL8 53 epithelial tumors 53 fig. S1 53 JAK2 V#F 53 gene duplications 53 codon 53 enolase 53 ploidy 53 chromosomal anomalies 53 mutant alleles 53 renal cell carcinomas 53 noncarriers 53 upregulated 53 rRNA 53 PCR amplified 53 FABP 53 Single Nucleotide Polymorphisms SNPs 53 colocalization 53 micro RNA 53 poor metabolizers 53 Cathepsin B 53 miRNA expression 53 noncoding RNAs 53 subfamily 53 Fig. 3b 53 TIMP 53 micrometastasis 53 unmutated 53 S#A# [002] 53 leukemic cell 53 imprinted genes 53 TET2 53 Transcriptome 53 TRAF1 C5 53 leptin receptor 53 parkinsonism 53 polyploid 53 IgG antibody 53 ß1 53 PGCs 53 serine 53 catenin 53 KLF# 53 COX2 53 #q# deletion 53 homologs 53 susceptibility alleles 53 affective psychosis 53 presenilin 53 ERBB4 53 YKL 53 multivariable analysis 53 mutated gene 53 Genotype 53 conserved sequences 53 BRCA2 53 genotyped 53 Rap1 53 V Leiden 53 NRTI resistance 53 postsynaptic 53 pseudogene 53 genomic alterations 53 FCGR3A 53 micrometastases 53 elevated LDH 53 microRNA miR 53 FXTAS 53 essential thrombocythemia 53 ortholog 53 ApoE gene 53 K ras 53 p tau 53 histone modifications 53 COMT 53 c fos 53 autosomal recessive disease 53 ERCC1 53 TP# gene 53 inducible nitric oxide synthase 53 ncRNAs 53 P. falciparum 53 OPRM1 53 lung adenocarcinomas 53 serum BDNF 53 cerebellar 53 glucose transporter 53 #q#.# deletion syndrome 53 heterochromatic 53 ERalpha 53 proapoptotic 53 GLUT1 53 Single Nucleotide Polymorphisms 53 hepatic lipase 53 ankyrin repeat 53 phosphorylates 53 ErbB2 53 methylation 53 Apolipoprotein E 53 serum triglycerides 53 FDG uptake 53 Fig. 2C 53 neuroligins 53 alanine aminotransferase 53 NSCLC tumors 53 androgen receptor gene 53 MC4R 53 STAT4 53 IGF1 53 T2 lesions 53 qRT PCR 53 BRAF mutation 53 monocytic 53 nicotine receptor 53 syngeneic 52 isoform 52 Allele 52 SSc 52 FUS1 52 syntaxin 52 KIT mutations 52 meningiomas 52 RAR beta 52 melanocyte 52 ependymomas 52 dentate gyrus 52 Single Nucleotide Polymorphism 52 protein kinase C 52 eIF4E 52 perivascular 52 ETV1 52 papillary renal cell carcinoma 52 phosphorylase 52 Subtype 52 transmembrane receptor 52 fibulin 52 ribosomal RNA rRNA 52 androgen receptor AR 52 phenotypes 52 transmembrane 52 COOH terminal 52 Figure 2C 52 plasma kallikrein 52 centromere 52 aminotransferase 52 T2 weighted images 52 β amyloid 52 HLA DRB1 SE 52 cytosine 52 CYP# [002] 52 isoenzyme 52 EGF receptors 52 transthyretin 52 NNRTI resistance 52 gene loci 52 neuroblastoma tumors 52 homolog 52 gene mutations 52 commonly mutated genes 52 karyotypes 52 GATA4 52 selective antagonists 52 transcriptionally active 52 tryptophan hydroxylase 52 synteny 52 histological subtype 52 Hepatocyte 52 pancreatic endocrine 52 E cadherin 52 apoE 52 histologically 52 BRAF gene 52 Fig. 3B 52 granzyme B 52 KRAS gene 52 MC4R gene 52 APOE e4 allele 52 colorectal adenocarcinoma 52 CFTR cystic fibrosis transmembrane 52 abdominal adiposity 52 BRCA mutations 52 superior temporal gyrus 52 evolutionary conserved 52 apparent diffusion coefficient 52 wildtype 52 plasmacytoid 52 receptor subtypes 52 dizygotic twins 52 ApoE4 gene 52 cytosine methylation 52 gene expression profiles 52 fronto temporal dementia 52 Fas ligand 52 nucleic acid sequence 52 gene rearrangements 52 colorectal adenomas 52 GBA mutations 52 DNA rearrangements 52 myopathies 52 C. trachomatis 52 FGFR2 gene 52 pDC 52 MicroRNA 52 FUS TLS 52 ORMDL3 52 Trypanosoma brucei 52 ataxin 52 HER2 overexpression 52 modifier genes 52 lung adenocarcinoma 52 NF1 52 BDNF gene 52 INF2 52 neoplastic cells 52 KIF6 gene variant 52 oligodendrogliomas 52 Histopathologic 52 glutamic acid decarboxylase 52 retrotransposon 52 Janus kinase 52 methyltransferase 52 ADAM# 52 p# activation 52 GISTs 52 human herpesvirus 52 tau gene 52 RhoA 52 huntingtin gene 52 huntingtin 52 aberrant methylation 52 KCNE2 52 FOXO3a 52 extramedullary 52 phosphorylated tau 52 transcriptional coactivator 52 phospholipase 52 Fig. 1A 52 ataxias 52 dominantly inherited 52 β 52 1beta 52 HLA DQ 52 histopathologic 52 Premature Aging 52 Mutational 52 B7 H3 52 deacetylation 52 CD3 + 52 Cytogenetic 52 HER2 gene 52 ß catenin 52 BRCA2 carriers 52 Genotypic 52 uncharacterized genes 52 GTPase 52 immunostaining 52 β1 52 PAK1 52 periodontal pathogens 52 glioblastoma tumors 52 aldehyde dehydrogenase 52 cytogenetic 52 lymphocytic 52 KIF6 52 Signaling Pathway 52 CYP#E# gene 52 orthologous genes 52 Cyclin D1 52 thyrotropin 52 Monocyte 52 astrocytomas

Back to home page